پِتّے کا کینسر

Evidence suggests distinct models of molecular and pathologic progression, and a growing body of genetics data points to a heterogeneous collection of underlying mutations in key oncogenes and tumor suppressor genes. Although tumor genetics have been used to tailor individual treatment regimens and guide clinical decision making in other cancers, these principles have not been applied in gallbladder malignancy. Recent clinical trials with targeted therapies seem promising, although the relationships between subsets of patients with positive responses to therapy and tumor genetics remain unexpl…

اسپانسر: بنارس ہندو یونیورسٹی
ClinicalTrials.gov پر NCT05404347
رجسٹری پر آخری اپڈیٹ 13 اگست 2024 · ہم نے 20 اکتوبر 2026 کو پڑھا